Clinical Evidence on EksoGT
Clinical Studies: Ongoing and Completed
Since 2012, Ekso Bionics, Inc. has sponsored or supported clinical research using the Ekso 1.1 and EksoGT exoskeletons. The vast majority of completed and ongoing studies are investigator-initiated. As of December 2018, over 2000 participants have been or are involved in 58 completed studies and 39 ongoing studies. Roughly half of the research is conducted within the U.S with the remainder within the EMEA. Because the first Ekso device was designed for those with spinal cord injury (SCI), most early research was conducted with SCI participants. With newer hardware and software accommodating more impairments, studies in patients with stroke and other neurological diagnoses have been quickly increasing. As expected, many of the feasibility studies have led to larger studies (single-arm or comparative) where the investment of time and resources is considerable. Ekso Bionics, Inc. remains committed to demonstrating clinical benefit through research. The graph below shows how the areas of the current EksoGT research are now more diversified.
Publications and Presentations
Past research activity using the Ekso devices has culminated in over 55 conference presentations, chapters, and published articles including 12 review articles. Of the published articles, 33 describe results of Ekso use in individuals with spinal cord injury, seven report on research related to Ekso in stroke survivors, and one pertains to multiple sclerosis. In addition to gait function and balance, 2018 publications included changes in secondary complications, motor control, and neuroplasticity with EksoGT training.
*The EksoGT is cleared for use with stroke and SCI populations. See the Indications for Use for more details.